Kostaive poeder voor dispersie voor injectie COVID-19 sa-mRNA-vaccin

{
  "form": "Dispersie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/kostaive-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Covid-19, RNA-based vaccine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131625",
  "excipients": [
    "1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLEENGLYCOL-2000",
    "1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE",
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "CHOLESTEROL",
    "KALIUMSORBAAT (E 202)",
    "NATRIUMCHLORIDE",
    "PENTADECAAN-8-YL 4-(3-(DIMETHYLAMINO)PROPYLSULFANYLCARBONYL-(4-OXO-4-PENTADECAAN-8-YLOXYBUTYL)AMINO)BUTANOAAT",
    "POLOXAMEER 188",
    "SACCHAROSE",
    "TROMETAMOL"
  ],
  "substances": [
    "ZAPOMERAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/02/12",
  "procedure_number": "EMEA/H/C/006207",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1873",
  "additional_monitoring": "Y"
}